ARPE-19-derived VEGF-containing exosomes promote neovascularization in HUVEC: the role of the melanocortin receptor 5.

retinal pigment epithelial cells cultured in a medium containing 35 mM D-glucose led to an augmented formation and release of vascular endothelial factor (VEGF)-containing exosomes compared to duanyu37E-19 cells cultured in a medium containing 5 mM D-glucose (standard medium). Exposing these cells to the melanocortin 5 receptor agonist (MCR₅) PG-901 (10^-10M), for 9 d reduced duanyu1670 generation, the number of exosomes released and their VEGF content. In contrast, incubating the cells with the melanocortin receptor MCR₁ agonist BMS-470539 (10^-5 M) or with the mixed MCR_3/4 agonist MTII (0.30 nmol) did not produce any significant decrease in duanyu1670 levels. VEGF-containing exosomes promoted neovascularization in human umbilical vein endothelial cells (HUVEC), an effect that was markedly reduced by PG-901 (10^-10M) but not by the MCR_3/4 agonist MTII (0.30 nmol) or the MCR₁ agonist BMS-470539 (10^-5 M). The MCR₅-related action in the duanyu37E-19 cells was accompanied by the increased expression of two coupled factors, cytochrome p4502E1 (CYP2E1) and nuclear factor kappa b (Nf-κB). These are both involved in high glucose signalling, in duanyu1670 generation and, interestingly, were reduced by the MCR₅ agonist in the duanyu37E-19 cells. Altogether, these data suggest that MCR₅ is a modulator of the responses stimulated by glucose in duanyu37E-19 cells, which might possibly be translated into a modulation of the retinal pigment epithelium response to diabetes in vivo.

KEYWORDS: {{ getKeywords(articleDetailText.words) }}